Celcuity (CELC) Current Leases (2018 - 2025)

Celcuity (CELC) posted Current Leases of $54000.0 for Q4 2025, down 43.75% on a QoQ basis from $96000.0 in Q3 2025, and down 68.6% year-over-year from $172000.0 in Q4 2024.

Celcuity (CELC) Current Leases (2018 - 2025) Analysis & Trends

Celcuity's Current Leases history runs 8 years deep, the most recent figure standing at $54000.0 for Q4 2025.

  • Quarterly Current Leases fell 68.6% year-over-year to $54000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $54000.0 (down 68.6% YoY) and the FY2025 annual result came in at $54000.0, down 68.6% from the prior year.
  • Current Leases was $54000.0 for Q4 2025 at Celcuity, down from $96000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $194895.0 in Q1 2023 and bottomed at $5379.0 in Q2 2022.
  • A 5-year average of $133890.2 and a median of $173613.0 in 2024 frame the typical range for Current Leases.
  • Annual changes were most pronounced in 2022 — Current Leases slumped 96.5% — and 2023, when it jumped 3457.04%.
  • Celcuity's Current Leases stood at $189858.0 in 2021, then gained by 1.0% to $191749.0 in 2022, then dropped by 3.55% to $184950.0 in 2023, then declined by 7.0% to $172000.0 in 2024, then plunged by 68.6% to $54000.0 in 2025.
  • Business Quant data shows CELC's Current Leases at $54000.0 in Q4 2025, $96000.0 in Q3 2025, and $139000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 531,233.95
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 20.58 Mn
4 NuCana 279.75 Bn 279.75 Bn - 872,589.03
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 720.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 11.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 16.61 Mn
10 Celcuity 4.13 Bn 4.13 Bn - 54,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 54,000.00
Sep 30, 2025 96,000.00
Jun 30, 2025 139,000.00
Mar 31, 2025 169,000.00
Dec 31, 2024 172,000.00
Sep 30, 2024 175,226.00
Jun 30, 2024 178,587.00
Mar 31, 2024 181,882.00
Dec 31, 2023 184,950.00
Sep 30, 2023 188,100.00
Jun 30, 2023 191,333.00
Mar 31, 2023 194,895.00
Dec 31, 2022 191,749.00
Sep 30, 2022 194,643.00
Jun 30, 2022 5,379.00
Mar 31, 2022 5,860.00
Dec 31, 2021 189,858.00
Sep 30, 2021 5,840.00
Jun 30, 2021 153,684.00
Mar 31, 2021 5,819.00